Li L, An J, Bai J, Zhang Y, Li X, Lv H
Front Endocrinol (Lausanne). 2025; 16:1539594.
PMID: 40017693
PMC: 11864960.
DOI: 10.3389/fendo.2025.1539594.
Hasan N, Chow E, Yang D, Iyer P, Reikes A
J Community Hosp Intern Med Perspect. 2025; 14(6):97-100.
PMID: 39839171
PMC: 11745181.
DOI: 10.55729/2000-9666.1407.
Feng L, Lu K, Li C, Xu M, Ye Y, Yin Y
BMC Musculoskelet Disord. 2025; 26(1):45.
PMID: 39806379
PMC: 11726928.
DOI: 10.1186/s12891-025-08276-w.
Stumpf U, Schmidmaier R, Taipaleenmaki H, Bocker W, Kurth A, Hesse E
Z Rheumatol. 2025; 84(2):107-112.
PMID: 39806104
DOI: 10.1007/s00393-024-01610-y.
Yan K, Zhang R, Wang J, Chen H, Zhang Y, Cheng F
Ann Med. 2025; 57(1):2449225.
PMID: 39749683
PMC: 11703118.
DOI: 10.1080/07853890.2024.2449225.
High prevalence of low bone mineral density in middle-aged adults in Shanghai: a cross-sectional study.
Chen Q, Liu D, Li X, Li F, Guo S, Wang S
BMC Musculoskelet Disord. 2024; 25(1):1097.
PMID: 39736676
PMC: 11687169.
DOI: 10.1186/s12891-024-08239-7.
Research on DXA bone density measurements and trabecular bone scores in Chinese men and women with obesity before and after bariatric surgery.
You H, Shang J, Huang Z, He W, Zeng C, Xu H
Sci Rep. 2024; 14(1):29355.
PMID: 39592749
PMC: 11599751.
DOI: 10.1038/s41598-024-80107-9.
Osteoporosis testing and treatment remain low in both Traditional Medicare and Medicare Advantage.
Azad T, Wu R, Anderson K, Darden M, Jain A
Osteoporos Int. 2024; 36(2):275-281.
PMID: 39570337
DOI: 10.1007/s00198-024-07318-8.
Inverted U-shaped association between total testosterone with bone mineral density in men over 60 years old.
Ma J, Zhao J, Wu N, Han M, Yang Z, Chen H
BMC Endocr Disord. 2024; 24(1):249.
PMID: 39558326
PMC: 11572123.
DOI: 10.1186/s12902-024-01780-5.
Research trends in exercise therapy for the treatment of pain in postmenopausal osteoporosis over the past decade: A bibliometric analysis.
Dai Z, Gong X, Zhang R, Jin M, Lu W, Wen W
World J Orthop. 2024; 15(10):950-964.
PMID: 39473512
PMC: 11514546.
DOI: 10.5312/wjo.v15.i10.950.
Changes of bone turnover markers and bone mineral density among postmenopausal Thai women with osteoporosis receiving generic risedronate.
Suwan A, Tanavalee C, Panyakhamlerd K, Ngarmukos S, Chavaengkiat S, Tanavalee A
BMC Womens Health. 2024; 24(1):572.
PMID: 39462376
PMC: 11515129.
DOI: 10.1186/s12905-024-03404-5.
Updated practice guideline for dual-energy X-ray absorptiometry (DXA).
Slart R, Punda M, Ali D, Bazzocchi A, Bock O, Camacho P
Eur J Nucl Med Mol Imaging. 2024; 52(2):539-563.
PMID: 39316095
PMC: 11732917.
DOI: 10.1007/s00259-024-06912-6.
Change in body temperature, not acute-phase reaction, predict anti-Osteoporosis efficacy after the first administration of Zoledronic acid: a prospective observational cohort study.
Du Y, Yu W, Gou H, Lei Y, Zhang T, Tang W
BMC Musculoskelet Disord. 2024; 25(1):694.
PMID: 39223504
PMC: 11367990.
DOI: 10.1186/s12891-024-07781-8.
Association of apolipoprotein A1 levels with lumbar bone mineral density and β-CTX in osteoporotic fracture individuals: a cross-sectional investigation.
Feng L, Lu K, Li C, Xu M, Ye Y, Yin Y
Front Med (Lausanne). 2024; 11:1415739.
PMID: 39144661
PMC: 11322117.
DOI: 10.3389/fmed.2024.1415739.
Effectiveness of Spironolactone in Reducing Osteoporosis and Future Fracture Risk in Middle-Aged and Elderly Hypertensive Patients.
Song S, Cai X, Hu J, Zhu Q, Shen D, Ma H
Drug Des Devel Ther. 2024; 18:2215-2225.
PMID: 38882049
PMC: 11180452.
DOI: 10.2147/DDDT.S466904.
Disturbed glycolipid metabolism activates CXCL13-CXCR5 axis in senescent TSCs to promote heterotopic ossification.
Chen Y, Wu J, Wong C, Gao W, Qi X, Zhou H
Cell Mol Life Sci. 2024; 81(1):265.
PMID: 38880863
PMC: 11335191.
DOI: 10.1007/s00018-024-05302-3.
Risk factors and clinical prediction models for osteoporosis in pre-dialysis chronic kidney disease patients.
Kuang C, Shang J, Ma M, Huang S, Yan B, Zhong Y
Ren Fail. 2024; 46(2):2361802.
PMID: 38874080
PMC: 11182074.
DOI: 10.1080/0886022X.2024.2361802.
Grape seed extract prevents oestrogen deficiency-induced bone loss by modulating the gut microbiota and metabolites.
Lu L, Li J, Liu L, Wang C, Xie Y, Yu X
Microb Biotechnol. 2024; 17(6):e14485.
PMID: 38850270
PMC: 11162104.
DOI: 10.1111/1751-7915.14485.
A practical approach for anabolic treatment of bone fragility with romosozumab.
Cianferotti L, Cipriani C, Palermo A, Viapiana O, Zavatta G, Mazziotti G
J Endocrinol Invest. 2024; 47(11):2649-2662.
PMID: 38789679
DOI: 10.1007/s40618-024-02395-2.
Observation of the Short-term Efficacy of Technetium-99 Conjugated with Methylene Diphosphonate Combined Therapy in the Treatment of Postmenopausal Osteoporosis.
Sun W, Xie Q, Yan J, Huang Y, Zhou Y, Xiao H
Comb Chem High Throughput Screen. 2024; 27(13):1930-1937.
PMID: 38357942
DOI: 10.2174/0113862073266467231228124942.
